Browse
S-Space
College of Medicine/School of Medicine (의과대학/대학원)
Program in Clinical Pharmacology (협동과정-임상약리학전공)
Theses (Ph.D. / Sc.D._협동과정-임상약리학전공)
췌장암 세포주에서 suberoylanilide hydroxamic acid (SAHA)와 bortezomib의 병합 투여가 gemcitabine의 항암 효과에 미치는 영향 및 기전
(The)anti-cancer effect and its mechanism of combination of suberoylanilide hydroxamic acid (SAHA) and bortezomib with gemcitabine in pancreatic cancer cell lines
- Authors
- 이준규
- Advisor
- 신상구
- Issue Date
- 2008
- Publisher
- 서울대학교 대학원
- Keywords
- 췌장암; Pancreatic cancer; SAHA; SAHA; Bortezomib; Bortezomib; gemcitabine; Gemcitabine; Akt; Akt; Bcl-xL; Bcl-xL; NFκB; NFκB
- Description
- 학위논문(박사) --서울대학교 대학원 :협동과정(임상약리학전공),2008. 8.
- Language
- Korean
- URI
- http://dcollection.snu.ac.kr:80/jsp/common/DcLoOrgPer.jsp?sItemId=000000041773
http://hdl.handle.net/10371/18602
- Files in This Item: There are no files associated with this item.
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.